ASTELLAS PHARMA INC./ JP3942400007 /
2024-07-25 10:59:57 PM | Chg. +0.236 | Volume | Bid10:59:57 PM | Ask10:59:57 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
9.840EUR | +2.46% | - Turnover: - |
9.840Bid Size: - | 10.030Ask Size: - | 18.17 bill.EUR | - | - |
GlobeNewswire
04-16
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Dir...
GlobeNewswire
03-19
Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degene...
GlobeNewswire
02-26
FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire
02-07
LAPIX Therapeutics Strengthens Board of Directors with Appointments of Pharmaceutical Industry Veter...
GlobeNewswire
2023-12-11
Basilea announces that FDA approves expanded use of antifungal Cresemba® (isavuconazole) in the Unit...
GlobeNewswire
2023-10-19
Basilea announces acquisition of novel clinical-stage antifungal for treatment of Aspergillus mold i...
GlobeNewswire
2023-09-14
Mineralys Therapeutics Expands its Board of Directors with Appointments of Glenn Sblendorio and Daph...
GlobeNewswire
2023-09-11
Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors
GlobeNewswire
2022-03-11
ENTA Conducting Clinical Trial of Investigational Regenerative Medication to Restore Hearing Functi...
GlobeNewswire
2022-02-28
Vallon Pharmaceuticals Announces Appointment of Meenu Karson to Board of Directors
GlobeNewswire
2022-02-22
Zenith Epigenetics Announces Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol...
GlobeNewswire
2022-01-31
Zenith Epigenetics Announces Appointment to Board of Directors and Provides Clinical Update